Reckitt Benckiser Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
1:13-cv-01461
Overview
Parties
Defendant
LTS Lohmann Therapy Systems Corp. Operating Company
Represented By
1 Attorneys ListedBayard, P.A.
Bayard, P.A., 600 N. King Street
Par Pharmaceutical Inc. Operating Company
Represented By
6 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Counter Claimant
IntelGenX Technologies Corp. NPE (Patent Assertion Entity)
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Counter Defendant
MonoSol Rx LLC Operating Company
Represented By
5 Attorneys ListedWomble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Womble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
RB Pharmaceuticals Limited NPE (University / Research)
Represented By
2 Attorneys ListedWomble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Womble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Reckitt Benckiser Pharmaceuticals Inc. Operating Company
Represented By
6 Attorneys ListedWomble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Womble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,170,150 B2 Asserted | US Continuation / Sibling | View Official Patent → |
Dr. Reddy’s Laboratories, Inc. et al. v. MonoSol Rx, LLC et al.
Par Pharmaceutical, Inc. et al. v. MonoSol Rx, LLC et al.
Mylan Technologies, Inc. et al. v. MonoSol Rx, LLC et al.
Dr. Reddy’s Laboratories, Inc. et al. v. Indivior UK Limited et al.
Dr. Reddy’s Laboratories, Inc. et al. v. MonoSol Rx, LLC et al.
Dr. Reddy's Laboratories, Inc. et al. v. MonoSol Rx, LLC et al.
Teva Parmaceuticals USA Inc. v. MONOSOL RX, LLC et al.
Teva Pharmaceuticals USA Inc v. MONOSOL RX LLC et al.
Teva Pharmaceuticals USA, Inc. v. Indivior UK Limited et al.
BioDelivery Sciences International, Inc. v. RB Pharmaceuticals Limited
Aquestive Therapeutics, Inc. v. BioDelivery Sciences International, Inc.
Indivior Inc. v. Actavis Laboratories UT, Inc.
Indivior Inc. v. Teva Pharmaceuticals USA, Inc.
Indivior Inc. v. Mylan Technologies Inc.
Indivior Inc. v. Biodelivery Sciences International, Inc.
Indivior Inc. v. Alvogen Pine Brook LLC
Indivior, Inc. v. Dr. Reddy's Laboratories S.A.
BioDelivery Sciences International, Inc. v. Reckitt Benckiser Pharmaceuticals, Inc.
Reckitt Benckiser Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
Reckitt Benckiser Pharmaceuticals Inc. v. Alvogen Pine Brook Inc
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8170150
Digitally controlled phase interpolator circuit
|
Filed: 2008-03-21
Issued: 2012-05-01
|
Active (2.9 yrs remaining)
+590d PTA
Expires: 2029-11-01
|
|
|
US8475832
Sublingual and buccal film compositions
|
Filed: 2009-08-07
Issued: 2013-07-02
|
Active (3.3 yrs remaining)
+231d PTA
Expires: 2030-03-26
|
|
|
US8017150
Polyethylene oxide-based films and drug delivery systems made therefrom
|
Filed: 2008-04-22
Issued: 2011-09-13
|
Expired (Term Ended)
Expires: 2023-10-10
|
|
|
US8603514
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
Filed: 2007-07-10
Issued: 2013-12-10
|
Expired (Term Ended)
Expires: 2024-04-03
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
High PTA (+590 days) / Cellect Scrutiny — Over 590 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
18
Dispositive
6
Granted
2
Denied
0
Pending / Review
8
Motions by Category
Key Dispositive Motions & Rulings